[HTML][HTML] Nanostructured lipid carriers for delivery of chemotherapeutics: A review
The efficacy of current standard chemotherapy is suboptimal due to the poor solubility and
short half-lives of chemotherapeutic agents, as well as their high toxicity and lack of …
short half-lives of chemotherapeutic agents, as well as their high toxicity and lack of …
Solid lipid nanoparticles vs. nanostructured lipid carriers: a comparative review
Solid–lipid nanoparticles and nanostructured lipid carriers are delivery systems for the
delivery of drugs and other bioactives used in diagnosis, therapy, and treatment procedures …
delivery of drugs and other bioactives used in diagnosis, therapy, and treatment procedures …
Solid lipid nanoparticles for targeted natural and synthetic drugs delivery in high-incidence cancers, and other diseases: Roles of preparation methods, lipid …
Solid lipid nanoparticles (SLNs), the spheroidal-shaped, colloids state lipophilic-natured,
innovative nanoscale particulate materials, are being concurrently prepared by the quality …
innovative nanoscale particulate materials, are being concurrently prepared by the quality …
Pharmaceutical amorphous nanoparticles
R Jog, DJ Burgess - Journal of pharmaceutical sciences, 2017 - Elsevier
There has been a tremendous revolution in the field of nanotechnology, resulting in the
advent of novel drug delivery systems known as nanomedicines for diagnosis and therapy …
advent of novel drug delivery systems known as nanomedicines for diagnosis and therapy …
Nanostructured lipid carriers: A potential use for skin drug delivery systems
A Czajkowska-Kośnik, M Szekalska… - Pharmacological Reports, 2019 - Elsevier
Skin application of pharmaceutical products is one of the methods used for drug
administration. The problem of limited drug penetration via topical application makes …
administration. The problem of limited drug penetration via topical application makes …
Biomaterial-engineered intra-articular drug delivery systems for osteoarthritis therapy
Osteoarthritis (OA) is a progressive and degenerative disease, which is no longer confined
to the elderly. So far, current treatments are limited to symptom relief, and no valid OA …
to the elderly. So far, current treatments are limited to symptom relief, and no valid OA …
Encapsulation of NSAIDs for inflammation management: overview, progress, challenges and prospects
W Badri, K Miladi, QA Nazari, H Greige-Gerges… - International journal of …, 2016 - Elsevier
Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely prescribed
drugs. Debilitating diseases such as rheumatoid arthritis and osteoarthritis are commonly …
drugs. Debilitating diseases such as rheumatoid arthritis and osteoarthritis are commonly …
Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer
B Liu, L Han, J Liu, S Han, Z Chen… - International journal of …, 2017 - Taylor & Francis
Background Cervical cancer is a major world health problem for women. Currently, cancer
research focuses on improving therapy for cervical cancer using various treatment options …
research focuses on improving therapy for cervical cancer using various treatment options …
Nanotechnological strategies for osteoarthritis diagnosis, monitoring, clinical management, and regenerative medicine: recent advances and future opportunities
R Mohammadinejad, M Ashrafizadeh… - Current rheumatology …, 2020 - Springer
Abstract Purpose of Review In this review article, we discuss the potential for employing
nanotechnological strategies for the diagnosis, monitoring, and clinical management of …
nanotechnological strategies for the diagnosis, monitoring, and clinical management of …
Novel strategies against cancer: Dexibuprofen-loaded nanostructured lipid carriers
V Thiruchenthooran, M Świtalska, L Bonilla… - International journal of …, 2022 - mdpi.com
The aim of this work was to design innovative nanostructured lipid carriers (NLCs) for the
delivery of dexibuprofen (DXI) as an antiproliferative therapy against tumoral processes, and …
delivery of dexibuprofen (DXI) as an antiproliferative therapy against tumoral processes, and …